Clinical Trial Update: A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers the Phase 1/2 study of HRS-4642 in patients with advanced KRAS G12D-mutant solid tumors. The trial is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• HRS-4642

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced KRAS G12D Mutant Solid Tumors | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING